Saturday, September 6, 2008

NIMS' Acceleration Therapeutic Platform: Potential Non-Invasive Home Treatment Of Coronary Artery Disease

Marvin A Sackner, M.D., CEO, Chairman of the Board, Non-Invasive Monitoring Systems, Inc. (NIMS) (OTCBB:NIMU) announced that Professor Masatoshi Fujita and associates, Shiga University of Medical Sciences, Kyoto University Graduate School of Medicine, Kitano Hospital, Japan presented a paper on NIMS' Whole Body Periodic Acceleration (WBPA) technology at the European Society of Cardiology meeting held in Munich, Germany August 30 to September 3, 2008. More at...

Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or CABG) in key safety endpoints in patients with multi-vessel disease and diabetes. These data were presented here recently at the European Society of Cardiology meeting. More at...

0 comments: